CRMD CorMedix Inc. Stock Quote

CRMD [NASD]

Index	-	P/E	-	EPS (ttm)	-0.75	Insider Own	0.40%	Shs Outstand	38.05M	Perf Week	-5.13%
Market Cap	242.72M	Forward P/E	-	EPS next Y	-1.00	Insider Trans	4.60%	Shs Float	37.58M	Perf Month	-22.88%
Income	-23.70M	PEG	-	EPS next Q	-0.17	Inst Own	28.60%	Short Float	6.50%	Perf Quarter	-27.29%
Sales	0.30M	P/S	809.06	EPS this Y	57.20%	Inst Trans	-0.01%	Short Ratio	6.76	Perf Half Y	-31.46%
Book/sh	2.21	P/B	2.76	EPS next Y	-17.60%	ROA	-47.90%	Target Price	-	Perf Year	1.67%
Cash/sh	2.04	P/C	2.99	EPS next 5Y	-	ROE	-53.40%	52W Range	3.86 - 18.80	Perf YTD	-17.90%
Dividend	-	P/FCF	-	EPS past 5Y	23.30%	ROI	-49.90%	52W High	-67.55%	Beta	2.37
Dividend %	-	Quick Ratio	27.20	Sales past 5Y	2.60%	Gross Margin	14.10%	52W Low	58.03%	ATR	0.36
Employees	35	Current Ratio	27.20	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	35.26	Volatility	5.36% 5.62%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	6.80%	Profit Margin	-	Rel Volume	0.53	Prev Close	6.08
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 13 AMC	Payout	-	Avg Volume	361.09K	Price	6.10
Recom	2.00	SMA20	-8.67%	SMA50	-14.49%	SMA200	-26.54%	Volume	190,399	Change	0.33%

Feb-17-21

Initiated

Needham

Buy

$31

Sep-29-20

Initiated

JMP Securities

Mkt Outperform

$22

Sep-21-20

Initiated

Truist

Buy

$20

Dec-18-19

Initiated

B. Riley FBR

Buy

$48

Mar-26-19

Reiterated

H.C. Wainwright

Buy

$3 → $15

Dec-06-18

Initiated

ROTH Capital

Buy

Sep-25-17

Reiterated

H.C. Wainwright

Buy

$3 → $4

Aug-10-17

Reiterated

Rodman & Renshaw

Buy

$5 → $3

May-05-17

Reiterated

Rodman & Renshaw

Buy

$6 → $5

Nov-11-16

Reiterated

FBR & Co.

Outperform

$6 → $4

Mar-17-16

Reiterated

FBR Capital

Outperform

$7 → $6

Mar-03-16

Initiated

FBR Capital

Outperform

Nov-16-15

Reiterated

ROTH Capital

Neutral

$2.75 → $2.50

Oct-29-15

Reiterated

ROTH Capital

Neutral

$4.50 → $2.75

May-06-15

Downgrade

ROTH Capital

Buy → Neutral

$2.50 → $7.50

Dec-08-14

Reiterated

ROTH Capital

Buy

$3 → $2.50

Oct-03-11

Downgrade

Maxim Group

Buy → Hold

Jul-28-21 06:00AM	LAWSUITS FILED AGAINST ATHA, CRMD and OTLY - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
Jul-27-21 08:05PM	CRMD NOTICE: Investors With Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit Newsfile
04:24PM	SHAREHOLDER ALERT: JRVR CRMD OTLY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:14PM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
11:40AM	LAWSUITS FILED AGAINST CCIV, CRMD and PLL - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
11:00AM	CRMD Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces CorMedix Inc. Class Action and Encourages Shareholders to Contact the Firm ACCESSWIRE
09:00AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SPCE, OCGN and CRMD ACCESSWIRE
08:00AM	CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm GlobeNewswire
05:40AM	CLASS ACTION UPDATE for SPCE, DKNG and CRMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:50AM	INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jul-26-21 09:15PM	CRMD INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM Encourages CorMedix Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline - CRMD PR Newswire
06:53PM	CRMD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 20, 2021 in the Class Action Filed on Behalf of CorMedix Inc. Limited Shareholders Newsfile
05:23PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
04:30PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CorMedix Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 20, 2021 - CRMD Newsfile
03:03PM	SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CorMedix Inc. of Class Action Lawsuit and Upcoming Deadline CRMD GlobeNewswire
02:00PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COIN, CRMD and PLL ACCESSWIRE
12:42PM	CRMD INVESTOR NOTICE: Rosen Law Firm Encourages CorMedix Inc. Investors with Losses to Secure Counsel Before Important Deadline CRMD Business Wire
10:00AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of QFIN, COIN and CRMD ACCESSWIRE
10:00AM	CRMD Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces CorMedix Inc. Class Action and Encourages Shareholders to Contact the Firm PR Newswire
09:35AM	CORMEDIX ALERT: Investors With Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit - CRMD PR Newswire
Jul-23-21 08:20PM	SHAREHOLDER ALERT: DIDI COIN CRMD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
08:00PM	CORMEDIX ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CorMedix Inc. and Encourages Investors to Contact the Firm Business Wire
07:15PM	CRMD ALERT: Investors With Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit Business Wire
05:15PM	CLASS ACTION UPDATE for SRAC, COIN and CRMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
04:27PM	Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against CorMedix Inc. (CRMD) GlobeNewswire
03:05PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of RLX, COIN and CRMD ACCESSWIRE
02:45PM	CRMD CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against CorMedix Inc. ACCESSWIRE
11:00AM	CRMD Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces CorMedix Inc. Class Action and Encourages Shareholders to Contact the Firm ACCESSWIRE
09:35AM	CRMD INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against CorMedix Inc. Newsfile
Jul-22-21 09:03PM	Pomerantz Law Firm Announces the Filing of a Class Action Against CorMedix Inc. and Certain Officers - CRMD PR Newswire
Jun-10-21 08:30AM	CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program GlobeNewswire
Jun-09-21 08:30AM	CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference GlobeNewswire
May-27-21 08:30AM	CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-13-21 04:01PM	CorMedix Inc. Reports First Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
02:30PM	CorMedix, Inc. to Host Earnings Call ACCESSWIRE
08:30AM	CorMedix Inc. Announces Appointment of Chief Commercial Officer GlobeNewswire
May-05-21 08:00AM	CorMedix Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13 GlobeNewswire
May-03-21 03:01PM	CorMedix (CRMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Apr-28-21 08:30AM	CorMedix Inc. to Participate at the 7th Annual Truist Securities Life Sciences Summit GlobeNewswire
Apr-14-21 09:00AM	CorMedix Has Meeting With FDA on DefenCath Catheter Lock Solution NDA GlobeNewswire -15.37%
Apr-07-21 08:30AM	CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference GlobeNewswire
Mar-30-21 04:05PM	CorMedix Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update GlobeNewswire
Mar-25-21 10:35PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CorMedix Inc. - CRMD ACCESSWIRE +5.40%
Mar-24-21 03:00AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CorMedix Inc. - CRMD PR Newswire -6.95%
Mar-23-21 08:30AM	CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update on March 30 GlobeNewswire
Mar-21-21 09:57PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CorMedix Inc. - CRMD Newsfile
Mar-18-21 04:48PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CorMedix Inc. - CRMD PR Newswire
Mar-16-21 10:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CorMedix Inc. - CRMD ACCESSWIRE
Mar-15-21 08:30AM	CorMedix Approved to Sell $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program GlobeNewswire
Mar-14-21 09:36PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CorMedix Inc. - CRMD Newsfile
Mar-12-21 05:35AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CorMedix Inc. - CRMD PR Newswire
Mar-11-21 08:30AM	CorMedix Inc. Announces Contract Extension of Liz Masson-Hurlburt as Executive Vice President and Head of Clinical Operations GlobeNewswire +15.55%
Mar-09-21 10:24PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CorMedix Inc. - CRMD ACCESSWIRE +12.26%
Mar-08-21 05:00PM	CorMedix Inc. to Host Regulatory Update Conference Call GlobeNewswire -7.06%
12:30PM	Earnings Preview: CorMedix (CRMD) Q4 Earnings Expected to Decline Zacks
Mar-07-21 06:28PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CorMedix Inc. - CRMD Newsfile
Mar-04-21 11:00AM	Bronstein, Gewirtz & Grossman, LLC Notifies Investors of CorMedix Inc. (CRMD) Investigation ACCESSWIRE
Mar-03-21 03:01PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CorMedix Inc. - CRMD PR Newswire -10.24%
Mar-01-21 08:55AM	FDA Strikes Out CorMedix's DefenCath Application Benzinga -39.87%
08:30AM	CorMedix Receives Complete Response Letter From FDA for DefenCath Catheter Lock Solution GlobeNewswire
Feb-17-21 04:15PM	3 Top Biotech Stocks With Major Catalysts Approaching TipRanks
Feb-06-21 02:57AM	CorMedix Inc. (NASDAQ:CRMD): Is Breakeven Near? Simply Wall St.
Feb-02-21 08:05AM	The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment Benzinga +31.69%
Jan-21-21 08:30AM	CorMedix Inc. to Begin Trading on the Nasdaq Stock Exchange GlobeNewswire
Dec-01-20 12:21PM	Is CorMedix (CRMD) A Good Stock To Buy Now? Insider Monkey
Nov-30-20 12:00PM	CorMedix (CRMD) Upgraded to Buy: Here's Why Zacks
Nov-24-20 12:00PM	Here's Why Momentum Investors Will Love CorMedix (CRMD) Zacks +7.74%
Nov-18-20 08:30AM	CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed GlobeNewswire +7.97%
Nov-08-20 08:47AM	We Think CorMedix (NYSEMKT:CRMD) Can Afford To Drive Business Growth Simply Wall St.
Nov-05-20 06:55PM	CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM	CorMedix Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
02:30PM	CorMedix, Inc. to Host Earnings Call ACCESSWIRE
Nov-02-20 08:30AM	CorMedix Appoints Greg Duncan to its Board of Directors GlobeNewswire
Oct-29-20 08:30AM	CorMedix Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on November 5 GlobeNewswire
Oct-08-20 09:00AM	CorMedix to Participate in BIO Investor Forum Digital GlobeNewswire
Sep-17-20 08:30AM	CorMedix Appoints Paulo Costa to its Board of Directors GlobeNewswire
Sep-09-20 08:30AM	CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire
Sep-04-20 11:28AM	Insider Buys CorMedix's Stock Benzinga
Aug-31-20 07:47AM	CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Defencath GlobeNewswire
Aug-19-20 08:46AM	CorMedix (CRMD) Jumps: Stock Rises 9.8% Zacks
Aug-10-20 05:35PM	CorMedix (CRMD) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:05PM	CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business Update GlobeNewswire
Aug-07-20 11:10AM	Cormedix's Earnings: A Preview Benzinga -5.94%
Aug-03-20 04:05PM	CorMedix Inc. to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 10 GlobeNewswire -5.84%
Jul-27-20 04:05PM	CorMedix Announces Proposed Public Offering of Common Stock GlobeNewswire
Jul-09-20 08:58AM	CorMedix (CRMD) Jumps: Stock Rises 7.5% Zacks
Jul-08-20 08:30AM	CorMedix Inc. Reports Submission of Defencath New Drug Application GlobeNewswire +7.52%
Jun-09-20 09:38AM	Edited Transcript of CRMD earnings conference call or presentation 11-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-27-20 11:41AM	Is CorMedix Inc. (CRMD) A Good Stock To Buy? Insider Monkey
May-21-20 12:00PM	CorMedix (CRMD) Moves to Buy: Rationale Behind the Upgrade Zacks
May-17-20 08:48AM	Analyst Forecasts Just Got A Whole Lot More Bearish On CorMedix Inc. (NYSEMKT:CRMD) Simply Wall St.
May-11-20 07:35PM	CorMedix (CRMD) Reports Q1 Loss, Misses Revenue Estimates Zacks
04:10PM	CorMedix Inc. Reports First Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
08:30AM	CorMedix Inc. Announces Appointment of Chief Financial Officer GlobeNewswire
May-06-20 08:30AM	CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections (CRBSIs), and the Potential for Neutrolin® GlobeNewswire -5.77%
May-04-20 09:00AM	CorMedix Inc. to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 11 GlobeNewswire +11.86%
Apr-23-20 08:15AM	CorMedix Inc. Announces Contract Extension of Jack Armstrong as Executive Vice President and Head of Technical Operations GlobeNewswire
Apr-22-20 11:50AM	Top Ranked Momentum Stocks to Buy for April 22nd Zacks
08:00AM	CorMedix Completes Sale of $5.5 Million of NOL Tax Benefits through New Jersey Technology Business Tax Certificate Transfer Program GlobeNewswire
Apr-14-20 11:52AM	Will CorMedix Continue to Surge Higher? Zacks +9.80%

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. It primarily focuses on the development of its lead product candidate DefenCath/Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Masson-Hurlburt Elizabeth	EVP, Head of Clinical Ops	May 21	Sale	6.92	8,000	55,394	0	May 25 04:46 PM
Kaplan Myron	Director	May 17	Buy	6.03	15,000	90,477	165,034	May 19 05:40 PM
Lefkowitz Steven W	Director	Sep 04	Buy	3.99	5,715	22,816	60,498	Sep 09 08:47 AM
David Matthew T	Chief Financial Officer	Sep 03	Buy	4.07	1,150	4,680	1,150	Sep 08 08:38 AM
Kaplan Myron	Director	Sep 02	Buy	4.27	15,300	65,359	150,034	Sep 04 08:25 AM
Khan Mehmood	Director	Aug 19	Buy	4.90	17,837	87,472	178,767	Aug 20 05:53 PM
Khan Mehmood	Director	Aug 18	Buy	4.80	27,913	133,878	160,930	Aug 20 05:53 PM
ARMSTRONG JR. JOHN L.	Exec VP of Tech Operations	Aug 14	Buy	4.22	27,500	116,110	96,878	Aug 17 08:06 PM
Mounts Phoebe	General Counsel	Aug 13	Buy	4.03	2,525	10,176	7,200	Aug 17 07:08 PM
Kaplan Myron	Director	Aug 13	Buy	4.08	15,000	61,160	134,734	Aug 17 07:02 PM
Baluch Khoso	Chief Executive Officer	Aug 13	Buy	4.14	4,830	19,985	60,905	Aug 17 06:45 PM
DUNTON ALAN W	Director	Aug 12	Buy	3.95	5,000	19,750	6,250	Aug 14 05:29 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience